European Companies Search Engine
Name: Bayer Schering Pharma AG · Proxy policy · Corporate Purpose Hrb5 Jul 2011 German Trade Register Announcements, Germany (01/07/2011)
Overview
Text
Schering AG,
Berlin, Müllerstraße 178, 13353 Berlin
. Company: Bayer Schering Pharma AG (a) manufacture, purchase and sale, import and export of chemical and biotechnological products of all kinds, in particular 'Bayer Schering Pharma' and/or 'Schering', in particular medicinal products, basic medicinal products, diagnostics and vaccines for human and veterinary medicine and fine chemicals, radioactive substances and intermediates (b) the manufacture, purchase and sale of preparations and equipment for medical and laboratory use (c) participation in other undertakings of all kinds and carrying out related transactions; Representation rules: The version of the general representation scheme is amended of its own motion as follows: If a member of the Board of Management is appointed, the company alone represents it. If several members of the Board of Management have been appointed, the Company shall be represented by two members of the Board of Management or by a member of the Board of Management in association with an authorized representative. The Supervisory Board of the Company may grant individual members of the Management Board the right to represent them alone. Legal form: By resolution of the Annual General Meeting of May 31, 2011, the Articles of Association are amended to Section 1 (Company), 2 (Object).
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Bayer Schering Pharma GmbH, Berlin, Germany.
